DUCA, LEONARDO
DUCA, LEONARDO
Dipartimento di Medicina Sperimentale
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing
2023-01-01 Bellocchi, Mc; Scutari, R; Carioti, L; Iannetta, M; Marchegiani, G; Piermatteo, L; Coppola, L; Tedde, S; Duca, L; Malagnino, V; Ansaldo, L; Braccialarghe, N; D′Anna, S; Mercedes Santoro, M; DI LORENZO, A; Salpini, R; Teti, E; Svicher, V; Andreoni, M; Sarmati, L; Ceccherini-Silberstein, F
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli
2023-03-01 Salpini, R; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini Silberstein, F; Sarmati, L; V. Svicher.,
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL
2023-01-01 R, S; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini-Silberstein, F; Sarmati, L; Svicher., V
HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication
2023-01-01 Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage.
2023-01-01 Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; DI LORENZO, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; CECCHERINI SILBERSTEIN, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Paolo Caviglia, G; Svicher, V; Salpini, R
HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens
2023-01-01 Chenwi, Ca; Compagno, M; Benedetti, L; Duca, L; Matteucci, C; Ka'E, Ac; Piermatteo, L; Scutari, R; Khan, S; El Khalili, O; Ferrari, L; Malagnino, V; Teti, E; Bertoli, A; Salpini, R; Grelli, S; Iannetta, M; Sarmati, L; Andreoni, M; Ceccherini-Silberstein., F
Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response
2023-01-01 D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini Silberstein, F; Perbellini, R; Lampertico, P; Svicher., V
Kinetics of the Three HBsAg Isoforms along with HDV-RNA Predict Virological Response in CHD Patients Treated with Bulevirtide for 48 Weeks
2023-01-01 D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini-Silberstein, F; Perbellini, R; Lampertico, P; Svicher, V
KINETICS OF THE THREE HBSAG ISOFORMS ALONG WITH HDV-RNA PREDICT VIROLOGICAL RESPONSE IN CHD PATIENTS TREATED WITH BULEVIRTIDE UP TO 96 WEEKS P 215
2023-01-01 D’Anna, ; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini-Silberstein, F; Perbellini, R; Lampertico, P; Svicher., V
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort
2023-09-01 Cervo, A; Russo, A; Di Carlo, D; De Vito, A; Fabeni, L; D'Anna, S; Duca, L; Colpani, A; Fois, M; Zauli, B; Mancarella, G; Carraro, A; Bezenchek, A; Cozzi-Lepri, A; Santoro, M
Prevalence of HDV infection in Central Italy has remained stable across the last two decades with dominance of sub-genotypes 1 and characterized by elevated viral replication
2024-01-01 Salpini, R; Piermatteo, L; Torre, G; D'Anna, S; Khan, S; Duca, L; Bertoli, A; La Frazia, S; Malagnino, V; Teti, E; Iannetta, M; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Pellicelli, A; Galati, G; Moretti, A; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Marignani, M; Ceccherini-Silberstein, F; Baiocchi, L; Grelli, S; Sarmati, L; Svicher, V
Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli
2023-01-01 Piermatteo, L; Salpini, R; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini-Silberstein, F; Sarmati, L; Svicher, V
ULTRASENSITIVE HBV-RNA QUANTIFICATION AS A PROMISING BIOMARKER TO OPTIMIZE THE STAGING OF CHRONIC HBV INFECTION AND TO DETECT MINIMAL VIRAL ACTIVITY UNDER PROLONGED VIROLOGICAL SUPPRESSION AND OCCULT HBV INFECTION.
2023-01-01 Piermatteo, L; D’Anna, S; Duca, L; Torre, G; Guerra, Af; Boarini, C; Tavelli, A; Ventura, P; Ceccherini-Silberstein, F; Pietrangelo, A; D’Arminio Monforte, A; Abbati, G; Gill, U; Kennedy, P; Svicher, V; Salpini Oral presentation at the, R; Bari, M; 14-16 June, 2
Ultrasensitive HBV-RNA quantification by droplet digital PCR is a promising biomarker to optimize the staging of chronic HBV infection and to identify minimal viral activity under prolonged virological suppression.
2023-01-01 Salpini, R; Piermatteo, L; D’Anna, S; Duca, L; Torre, G; Guerra, Af; Boarini, C; Tavelli, A; Ventura, P; Ceccherini Silberstein, F; Pietrangelo, A; Puoti, M; D’Arminio Monforte, A; Abbati, G; Gill, U; Kennedy, P; Svicher, V
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2023 | Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing | Bellocchi, Mc; Scutari, R; Carioti, L; Iannetta, M; Marchegiani, G; Piermatteo, L; Coppola, L; Tedde, S; Duca, L; Malagnino, V; Ansaldo, L; Braccialarghe, N; D′Anna, S; Mercedes Santoro, M; DI LORENZO, A; Salpini, R; Teti, E; Svicher, V; Andreoni, M; Sarmati, L; Ceccherini-Silberstein, F | Articolo su rivista | |
| 1-mar-2023 | HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli | Salpini, R; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini Silberstein, F; Sarmati, L; V. Svicher., | Intervento a convegno | |
| 1-gen-2023 | HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL | R, S; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini-Silberstein, F; Sarmati, L; Svicher., V | Intervento a convegno | |
| 1-gen-2023 | HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication | Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2023 | Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. | Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; DI LORENZO, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; CECCHERINI SILBERSTEIN, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Paolo Caviglia, G; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2023 | HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens | Chenwi, Ca; Compagno, M; Benedetti, L; Duca, L; Matteucci, C; Ka'E, Ac; Piermatteo, L; Scutari, R; Khan, S; El Khalili, O; Ferrari, L; Malagnino, V; Teti, E; Bertoli, A; Salpini, R; Grelli, S; Iannetta, M; Sarmati, L; Andreoni, M; Ceccherini-Silberstein., F | Intervento a convegno | |
| 1-gen-2023 | Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response | D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini Silberstein, F; Perbellini, R; Lampertico, P; Svicher., V | Intervento a convegno | |
| 1-gen-2023 | Kinetics of the Three HBsAg Isoforms along with HDV-RNA Predict Virological Response in CHD Patients Treated with Bulevirtide for 48 Weeks | D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini-Silberstein, F; Perbellini, R; Lampertico, P; Svicher, V | Intervento a convegno | |
| 1-gen-2023 | KINETICS OF THE THREE HBSAG ISOFORMS ALONG WITH HDV-RNA PREDICT VIROLOGICAL RESPONSE IN CHD PATIENTS TREATED WITH BULEVIRTIDE UP TO 96 WEEKS P 215 | D’Anna, ; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini-Silberstein, F; Perbellini, R; Lampertico, P; Svicher., V | Intervento a convegno | |
| 1-set-2023 | Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort | Cervo, A; Russo, A; Di Carlo, D; De Vito, A; Fabeni, L; D'Anna, S; Duca, L; Colpani, A; Fois, M; Zauli, B; Mancarella, G; Carraro, A; Bezenchek, A; Cozzi-Lepri, A; Santoro, M | Articolo su rivista | |
| 1-gen-2024 | Prevalence of HDV infection in Central Italy has remained stable across the last two decades with dominance of sub-genotypes 1 and characterized by elevated viral replication | Salpini, R; Piermatteo, L; Torre, G; D'Anna, S; Khan, S; Duca, L; Bertoli, A; La Frazia, S; Malagnino, V; Teti, E; Iannetta, M; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Pellicelli, A; Galati, G; Moretti, A; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Marignani, M; Ceccherini-Silberstein, F; Baiocchi, L; Grelli, S; Sarmati, L; Svicher, V | Articolo su rivista | |
| 1-gen-2023 | Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli | Piermatteo, L; Salpini, R; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini-Silberstein, F; Sarmati, L; Svicher, V | Intervento a convegno | |
| 1-gen-2023 | ULTRASENSITIVE HBV-RNA QUANTIFICATION AS A PROMISING BIOMARKER TO OPTIMIZE THE STAGING OF CHRONIC HBV INFECTION AND TO DETECT MINIMAL VIRAL ACTIVITY UNDER PROLONGED VIROLOGICAL SUPPRESSION AND OCCULT HBV INFECTION. | Piermatteo, L; D’Anna, S; Duca, L; Torre, G; Guerra, Af; Boarini, C; Tavelli, A; Ventura, P; Ceccherini-Silberstein, F; Pietrangelo, A; D’Arminio Monforte, A; Abbati, G; Gill, U; Kennedy, P; Svicher, V; Salpini Oral presentation at the, R; Bari, M; 14-16 June, 2 | Intervento a convegno | |
| 1-gen-2023 | Ultrasensitive HBV-RNA quantification by droplet digital PCR is a promising biomarker to optimize the staging of chronic HBV infection and to identify minimal viral activity under prolonged virological suppression. | Salpini, R; Piermatteo, L; D’Anna, S; Duca, L; Torre, G; Guerra, Af; Boarini, C; Tavelli, A; Ventura, P; Ceccherini Silberstein, F; Pietrangelo, A; Puoti, M; D’Arminio Monforte, A; Abbati, G; Gill, U; Kennedy, P; Svicher, V | Intervento a convegno |